Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands

Journal of Medicinal Chemistry

Volumn 45, Issue 2, 2002, Pages 469-477

  Sun, Xiankai ^a   Wuest, Melinda ^a   Weisman, Gary R ^b   Wong, Edward H ^b   Reed, David P ^b   Boswell, C Andrew ^a   Motekaitis, Ramunas ^c   Martell, Arthur E ^c   Welch, Michael J ^a   Anderson, Carolyn J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Univ of New Hampshire   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,8,11 TETRAAZABICYCLO[6.6.2]HEXADECANE; 4,11 BIS(AMIDOETHYL) 1,4,8,11 TETRAAZABICYCLO[6.6.2]HEXADECANE; 4,11 BIS(CARBOXYMETHYL) 1,4,8,11 TETRAAZABICYCLO[6.6.2]HEXADECANE; 4,11 BIS(N,N DIETHYL AMIDOMETHYL) 1,4,8,11 TETRAAZABICYCLO[6.6.2]HEXADECANE; COPPER COMPLEX; CYCLAM DERIVATIVE; EDETIC ACID; METAL COMPLEX; RADIOPHARMACEUTICAL AGENT; TRIENTINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COMPLEX FORMATION; DIAGNOSTIC IMAGING; DISSOCIATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG STABILITY; ISOTOPE LABELING; NONHUMAN; RADIOTHERAPY; RAT;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; CHELATING AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; COPPER RADIOISOTOPES; DRUG STABILITY; FEMALE; HETEROCYCLIC COMPOUNDS; ISOTOPE LABELING; LIGANDS; LIVER; MALE; ORGANOMETALLIC COMPOUNDS; POTENTIOMETRY; PROTONS; RADIOPHARMACEUTICALS; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 0037122750     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0103817     Document Type: Article

References (77)

1. Encapsulation of cations and anions by azacrowns: Thermodynamic and structural aspects
2. Some general synthetic strategies towards macrocyclic systems
3. Factors affecting stabilities of chelate, macrocyclic and macrobicyclic complexes in solution
4. The complete coordination chemistry. One practitioner's perspective
5. Thermodynamic aspects of the polyazacycloalkane complexes with cations and anions
6. Ligand design for selective complexation of metal ions in aqueous solution
7. Metal complexes as diagnostic tools
8. Designing new MRI contrast agents: A coordination chemistry challenge
9. Recent advances in utilization of transition metal complexes and lanthanides as diagnostic tools
10. Stability and structure of activated macrocycles. Ligands with biological applications
11. Nitrogen donors in organometallic chemistry and homogeneous catalysis
12. Coordination compounds in nuclear medicine
13. Role of Zn(II) ion in zinc enzymes
14. Macrocyclic polyamines with intelligent functions
15. Tumor targeting with radiolabeled macrocycle-antibody conjugates
16. Synthetic and structural aspects of the chemistry of saturated polyaza macrocyclic ligands bearing pendant coordinating groups attached to nitrogen
17. Macrocyclic ligands with pendant amide and alcoholic oxygen donor groups
18. Complexes of polyaza macrocycles bearing pendant coordinating groups
19. Functionalized tetraazamacrocycles: Ligands with many aspects
20. Bridging alkylation of saturated polyaza macrocycles: A means for imparting structural rigidity
21. A rigidly trans-coordinating twelve-membered macrocycle
22. Structurally reinforced macrocyclic ligands
23. Metal complexes with macrocyclic ligands - Axial coordination tendency in reinforced tetraazamacrocyclic ligands
24. + complexation in a diamond-lattice cleft
25. Synthesis and transition-metal complexes of new cross-bridged tetraamine ligands
26. In/Out isomerism
27. Synthesis and characterization of cross-bridged cyclams and pendant-armed derivatives and structural studies of their copper(II) complexes
28. Ultra rigid cross-bridged tetraazamacrocycles as ligands - The challenge and the solution
29. The square-pyramidal PdII complex of a cross-bridged tetraazamacrocycle
30. Copper(I) and copper(II) complexes of an ethylene cross-bridged cyclam
31. New iron(II) and manganese(II) complexes of two ultra-rigid, cross-bridged tetraazamacrocycles for catalysis and biomimicry
32. Crystallographic characterization of stepwise changes in ligand conformation as their internal topology changes and two novel cross-bridged tetraazamacrocyclic copper(II) complexes
33. Aza-macrocycles bearing lipophilic functions. Their synthesis and selective lithium complexation
34. Synthesis and characterization of and aza-cage behaving as "proton sponge". Crystal structures of its mono- and triprotonated species
35. Synthesis and characterization of an aza-cage, basicity behaviour and crystal structure of its diprotonated species
36. Synthesis of [35]adamanzane, 1,5,9,13-tetraazatricyclo[7.7.3]-nonadecane, by oxidative C-N cleavage of [36]adamanzane, 1,5,9,13-tetraazatricyclo[7.7.3.35,13]docosane, and crystal structure of the tetraprotonated bromide salt of [35]adamanzane
37. Synthesis and crystal structure of a small bicyclic tetraaza proton sponge, 1,4,7,10-tetraazabicyclo[5.5.3]pentadecane dibromide perchlorate
38. A two-step synthesis of new macrobicyclic aza-ligands starting from "trans"dioxocyclam as diprotected macrocycle
39. Convenient synthesis of new tetraazamacrocycle-based macrobicycles
40. Convenient synthesis of new tetraazamacrocycle-based macrobicycles
41. Synthetic, thermodynamic and crystallographic studies of pentacoordinated copper(II) complexes with [24.31]adamanzane, 1,4,7,10-tetrazabicyclo[5.5.3]pentadecane, and bromide, iodide, hydroxide, water, or ammonia
42. Synthesis and crystal structure of a compound with three [24.31]adamanzanecopper(II) species coordinated to one carbonate ion, m3-carbonatotris-{1,4,7,10-tetraazabicyclo[5.5.3]pentadecanecopper(II)} perchlorate dihydrate
43. Structural aspects of the protonation of small cages. Preparation of the new aza-cage 12,17-Dimethyl-1,9,12,17-tetraazabicyclo [7.5.5]nonadecane (L). Thermodynamic studies on solution equilibria. Crystal structures of [H2l] [CoC14] and [H211]-[CoC14] salts
44. Nickel(II) complexes with [24.31]adamanzane, 1,4,7,10-tetraazabicyclo[5.5.3]pentadecane
45. The in vivo behavior of copper-64-labeled azamacrocyclic compounds
46. Labeling and in vivo evaluation of novel copper(II) dioxotetraazamacrocyclic complexes
47. Copper-67-labeled monoclonal antibody lym-1, a potential radiopharmaceutical for cancer therapy: Labeling and biodistribution in RAJI tumored mice
48. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: Biodistribution and metabolism
49. 67CU-antibody conjugate to ceruloplasmin in lymphoma patients
50. RadioimmunoPET: Detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody
51. Radioimmunotherapy with a Cu-64-labeled monoclonal antibody: A comparison with Cu-67
52. Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats
53. The efficient production of high specific activity CU-64 using a biomedical cyclotron
54. Copper chelates as probes of biological systems: Stable copper complexes with a macrocyclic bifunctional chelating agent
55. 57Co
56. Comparative serum stability of radiochelates for antibody radiopharmaceuticals
57. Evaluation of copper-labeled bifunctional chelate-albumin conjugates for blood pool imaging
58. In vitro and in vivo evaluation of copper-64-labeled octreotide conjugates
59. Pharmacology of 67-Cu-BAT-Lym1 monoclonal antibody in patients with B cell lymphoma
60. Enhancement of tumor uptake of monclonal antibody in nude mice with PEG-IL-2
61. 131I-labeled Lym-1 antibody: Comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma
62. Copper-64-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors
63. In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver
64. Unusual protonation constants of cyclam. A potentiometric, crystallographic and molecular mechanics study
65. Relationship between reduction potential and in vivo stability of copper azamacrocycle complexes
66. Regioselective carbonyl amination using diisobutylaluminum hydride
67. 1-octreotide